References
- Roberts J. M., Taylor R. N., Musici T. J., Rodgers G. M., Hubel C. A., McLaughlin M. K. Preeclampsia: An Endothelial Cell Disorder. Am. J. Obstet. Gynecol. 1989; 161: 1200–1204
- Salafia C. M., Pezzulo J. C., Lopez-Zeno J A., Minior V. K., Vintzileos A. M. Placental Pathologic Features of Preterm Preeclampsia. Am. J. Obstet. Gynecol. 1995; 173: 1079–1105
- Salafia C. M., Minior V. K., Pezzulo J. C., Popek E. J., Rosenkrantz T. S., Vintzileos A. M. Intrauterine Growth Restriction in Infants of Less than Thirty-two Weeks' Gestation: Associated Placental Pathologic Features. Am. J. Obstet. Gynecol. 1995; 173: 57
- Green Placenta J.R. Previa and Abruptio Placentae. Maternal Fetal Medicine: Principles and Practice, R. K. Creasy, R. Resnik. W.B. Saunders, Philadelphia 1994; 609–610
- Infante-Rievard C, David M., Gauthier R., Ribard G., Lupus E. Anticoagulants, Anticardiolipin Antibodies and Fetal Loss. N. Engl. J. Med. 1991; 325: 1063–1066
- Dekker G. A., de Vries J. I., Doelitzsch P. M., Huijgens P. C., von Blomberg B. M.E., Jakobs C., van Geijn H. P. Underlying Disorders Associated with Severe Early-Onset Preeclampsia. Am. J. Obstet. Gynecol. 1995; 173: 1042–1048
- Dizon-Townson D. S., Nelson L. M., Easton K., Ward K. The Factor V Leiden Mutation May Predispose Women to Severe Preeclampsia. Am. J. Obstet. Gynecol. 1996; 175: 902–905
- Grandone E., Margaglione M., Colaizzo D., Cappucci G., Paladini D., Martinelli P., Montanuro S., Payone G., Di Minno G., Factor V, Leiden C. T MTHFR Polymorphism and Genetic Susceptibility to Preeclampsia. Thromb. Haemost. 1997; 77: 1052–1054
- de Vries J. I., Dekker G. A., Huijgens P. C., Jakobs C., Blomberg B. M., van Geijn H. P. Hyperhomocystinemia and Protein S Deficiency in Complicated Pregnancies. Br. J. Obstet. Gynaecol. 1997; 104: 1248–1254
- Kupferminc M. J., Eldor A., Steinman N., Many A., Bar-Am A., Jaffa A., Fait G., Lessing J B. Increased Frequency of Genetic Thrombophilias in Women with Complications of Pregnancy. N. Engl. J. Med. 1999; 340: 9–13
- Caritis S., Sibai B., Hauth J., Lindheimer M. D., Klebanoff M., Thom E., van Dorsten P., Landon M., Paul R., Miodovnik M, Meis P., Thurnau G. Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk. N. Engl. J. Med. 1998; 338: 701–705
- Barth W., Jr. Low-Dose Aspirin for Preeclampsia—The Unresolved Question. N. Engl. J. Med. 1998; 338: 756–757
- Brenner W. E., Edelman D. A., Hendricks C. H. A Standard of Fetal Growth for the United States of America. Am. J. Obstet. Gynecol. 1976; 126: 555–564
- Brenner B., Zivelin A., Lanir N., Greengard J. S., Griffin J. H., Seligsohn U. Venous Thromboembolism Associated with Double Heterozygosity for R506Q Mutation of Factor V and for T298M Mutation of Protein C in a Large Family of a Previously Described Homozygous Protein Newborn with Massive Thrombosis. Blood 1996; 88: 877–880
- Frosst P., Blom H. J., Milos R., Goyette P., Sheppard C. A., Matthews R. G., Boers G. J., den Heijer M., Kluijtmans L. A., van der Hauvel L. P., et al. A Candidate Genetic Risk Factor for Vascular Disease: A Common Mutation in Methylenetetrahydrofolate Reductase. Nat. Genet. 1995; 10: 111–113
- Poort S. R., Rosendaal F. R., Reitsma P. H., Bertina R. M. A Genetic Variation in the 3′-Untranslated Region of the Prothrombin Gene Is Associated with Elevated Plasma Prothrombin Levels and an Increase in Venous Thrombosis. Blood 1996; 88: 3698–3703
- Sibai B. M., Caritis S. N., Thom E., Klebanoff M., McNeillis D., Rocco L., Paul R. H., Romero R., Witter F., Rosen M., et al. Prevention of Preeclampsia with Low-Dose Aspirin in Healthy, Nulliparous Pregnant Women. N. Engl. J. Med. 1993; 329: 1213–1218
- CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: A Randomised Trial of Low-Dose Aspirin for the Prevention and Treatment of Pre-eclampsia Among 9364 Pregnant Women. Lancet 1994; 343: 619–629
- Girling J., de Swiet M. Inherited Thrombophilia and Pregnancy. Curr. Opin. Obstet. Gynecol. 1998; 10: 135–144
- Branch D. W., Silver R. M., Blackwell J. L., Reading J. C., Scott J. R. Outcome of Treated Pregnancies in Women with Antiphospholipid Syndrome: An Update of the Utah Experience. Obstet-Gynecol. 1992; 80: 614–620
- Lima F., Khamashta M. A., Buchanan N. M., Kerslake S., Hunt B. J., Hughes G. R. A Study of Sixty Pregnancies in Patients with the Antiphospholipid Syndrome. Clin. Exp. Rheumatol. 1996; 14: 131–136
- Kutteh W. H. Antiphospholipid Antibody-Associated Recurrent Pregnancy Loss: Treatment with Heparin and Low-Dose Aspirin Is Superior to Low-Dose Aspirin Alone. Am. J. Obstet. Gynecol. 1966; 174: 1584–1589
- Fejgin M. D., Lourwood D. L. Low-Molecular-Weight Heparins and Their Use in Obstetrics and Gynecology. Obstet. Gynecol. Survey 1994; 49: 424–431
- Dulitzki M., Pauzner R., Langevitz P., Pras M., Many A., Schiff E. Low-Molecular-Weight Heparin During Pregnancy and Delivery: Preliminary Experience with 41 Pregnancies. Obstet. Gynecol. 1996; 87: 380–383
- Nelson-Piercy C., Letsky E. A., de Sweit M. Low-Molecular-Weight Heparin for Obstetric Thromboprophylaxis: Experience of Sixty-nine Pregnancies in Sixty-one Women at High risk. Am. J. Obstet. Gynecol. 1997; 176: 1062–1068
- Gillis S., Shushan A., Eldor A. Use of Low Molecular Weight Heparin for Prophylaxis and Treatment of Thromboembolism in Pregnancy. Int. J. Obst. Gyneacol. 1992; 39: 56–58
- Sibai B. M., El-Nazer A., Gonzalez-Ruiz A. Severe Preeclampsia-Eclampsia in Young Women: Subsequent Pregnancy Outcome and Remote Prognosis. Am. J. Obstet. Gynecol. 1986; 155: 1011–1016
- Pitchard J. A., Cunningham F. G., Pitchard S. A., Mason R. A. On Reducing the Frequency of Severe Abruptio Placentae. Am. J. Obstet. Gynecol. 1991; 165: 1345–1351
- Bakketeig L. S., Bjerkedal T., Hoffman H. J. Small-for-Gestational Births in Successive Pregnancy Outcome: Results from a Longitudinal Study of Births in Norway. Early Hum. Dev. 1986; 14: 187–200
- Tejani N. A. Recurrence of Intrauterine Growth Retardation. Obstet. Gynecol. 1982; 59: 329–331